Health related quality of life in older or frail patients with advanced colorectal cancer treated with dose reduced capecitabine
Daniel Breadner(Western University), Stephen Welch(Cancer Care Ontario), James Biagi(Queen's University), Anne C. O’Connell(Dublin Dental University Hospital), Larry Stitt(Western University), D. Jonker(Ottawa Hospital), C. Cripps(Canadian Partnership Against Cancer), Paul Klimo(St. Jude Children's Research Hospital), Mark Vincent, Frances Whiston, Wwt Lam(University of Hong Kong)
Cited by 4
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
|The Lancet|2018|1.3k
Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis
|International Journal of Radiation Oncology*Biology*Physics|2013|673